0.74
0.0011 (0.15%)
0.0011 (0.15%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 52,105 |
|
|||||
| News | - | ||||||
| Day High | 0.7698 | Low High |
|||||
| Day Low | 0.73 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| OncoSec Medical Incorporated | ONCS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.0011 | 0.15% | 0.74 | 18:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.74 | 0.73 | 0.7698 | 0.74 | 0.7389 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 101 | 52,105 | $ 0.7435579 | $ 38,743 | - | 0.67 - 4.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 6 | $ 0.7579 | USD |
Period:
Draw Mode:
OncoSec Medical Incorporated Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 29.12M | 39.35M | 18.99M | $ - | $ - | -1.40 | -0.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 6.80% |
OncoSec Medical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONCS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.72 | 0.769899 | 0.67 | 0.707634 | 63,144 | 0.02 | 2.78% |
| 1 Month | 1.00 | 1.02 | 0.67 | 0.7950376 | 78,890 | -0.26 | -26.0% |
| 3 Months | 0.80 | 1.45 | 0.67 | 1.02 | 89,666 | -0.06 | -7.5% |
| 6 Months | 1.78 | 1.79 | 0.67 | 1.07 | 160,525 | -1.04 | -58.43% |
| 1 Year | 3.68 | 4.25 | 0.67 | 2.81 | 555,993 | -2.94 | -79.89% |
| 3 Years | 4.515 | 8.1598 | 0.67 | 3.19 | 356,853 | -3.78 | -83.61% |
| 5 Years | 9.50 | 29.50 | 0.67 | 10.80 | 639,213 | -8.76 | -92.21% |
OncoSec Medical Description
| OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer. |